Physician profile
John C Li
NPI 1568459246
$937.17
in general payments reported to CMS, 2019-2025
13 companies · $98.01 in 2025
The $98.01 reported for 2025 was less than what a typical Otology & Neurotology provider received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.15 · 2020: $32.01 · 2021: $258 · 2022: $104 · 2023: $77.24 · 2024: $281 · 2025: $98.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $456.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $329.51 | 2021-2024 | Audion Et Dilation System, Xpress Loprofile, Entellus Medical Reinforced Anesthesia Needle |
| Cochlear Americas | $255.37 | 2020-2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Glaxosmithkline, LLC. | $108.16 | 2023-2024 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $46.73 | 2025 | Neffy |
| Med-El Corporation | $35.10 | 2019 | |
| Optinose US, INC. | $34.53 | 2019-2025 | |
| Medtronic, INC. | $25.11 | 2024 | Propel |
| Acell, INC. | $20.32 | 2019 | |
| Smith+Nephew, INC. | $18.58 | 2025 | |
| Merck Sharp & Dohme LLC | $18.13 | 2023 | |
| Genzyme Corporation | $15.73 | 2023 | |
| Integra Lifesciences Corporation | $15.53 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Aerin Medical INC. | $14.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.